Early Vision Screening in High-risk Children

F

Far Eastern Memorial Hospital

Status

Unknown

Conditions

Child
Amblyopia

Study type

Observational

Funder types

Other

Identifiers

NCT02678468
104077-F

Details and patient eligibility

About

To evaluate the effect of early vision screening with automated photorefraction device in high risk children

Full description

Pre-term, low-birth-weight, and development delay are well-known risk factors related to higher incidence of high refractive error and strabismus, which can potentially lead to amblyopia and is regarded as amblyopia risk factors. This project is a cross-sectional controlled study. Our study includes high-risk group and normal group. High-risk group includes children with birth history of pre-term, low-birth-weight and the diagnosis of development delay in FEMH. Normal group enrolled age-matched children without those risk factors. Vision screening by FDA-approved photorefraction device as well as comprehensive ophthalmic exams for definite diagnosis will be performed on the high-risk group and the normal group.

Enrollment

200 estimated patients

Sex

All

Ages

1 to 2 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • High risk group: children with gestational age less than 36weeks, birth weight less than 2500g and children diagnosed as develop delay
  • Normal group: children with normal birth history and normal development

Exclusion criteria

  • Children with known ophthalmic diseases
  • Children with congenital systemic diseases

Trial design

200 participants in 2 patient groups

high-risk group
Description:
children with birth history of pre-term, low birth weight children with develop delay
normal group
Description:
children with normal birth history and normal development

Trial contacts and locations

1

Loading...

Central trial contact

Yao-Lin Liu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems